On March 10, 2025, Cuu Long Pharmaceutical Joint Stock Company and Benovas Medical Equipment Joint Stock Company successfully organized a working session with the Ministry of Health for 2025 under the theme “Challenges & Opportunities.” This event provided an opportunity for businesses to share information and propose solutions to address obstacles and difficulties in their operations.
Attending the session were Mr. Nguyen Thanh Lam – Deputy Director of the Drug Administration of Vietnam; Mr. Nguyen Tri Dung – Deputy Director of the Health Insurance Department; Mr. Le Thanh Cong – Director of the National Center for Centralized Drug Procurement; Mr. Hoang Cuong – Deputy Director of the Department of Financial Planning; and Mr. Phan Tien Nghia – Representative from the National Center for Centralized Drug Procurement. On behalf of Cuu Long Pharmaceutical and Benovas, the attendees included Ms. Nguyen Thị Thu Huong – General Director of Benovas Pharmaceutical JSC and Assistant to the Chairman of the Board of Directors, responsible for internal operations of Cuu Long Pharmaceutical; Mr. Nguyen Trong Duc – Deputy General Director of Production & Procurement at Cuu Long Pharmaceutical JSC; Mr. Nguyen Ba The – Business Development Director; and Mr. Nguyen Toan Thang – General Director of Benovas Medical Equipment JSC.
Working Session Between Ministry of Health Representatives and Businesses.
This working session between the Ministry of Health representatives and businesses provided a valuable platform for the leadership and various departments of Cuu Long Pharmaceutical JSC and Benovas Medical Equipment JSC to discuss current issues, operational challenges, and propose practical solutions and initiatives to the Ministry of Health.
Through discussions and proposals from Cuu Long Pharmaceutical and Benovas, viable solutions were explored to promote the sustainable development of the pharmaceutical and medical equipment industry. These solutions aim to enhance the competitiveness of businesses within the broader context of integration and growth in the healthcare sector.
Speaking at the session, Mr. Nguyễn Thành Lâm – Deputy Director of the Drug Administration of Vietnam – emphasized the importance of ensuring product quality in protecting public health and advancing the pharmaceutical industry. He stated: “The Ministry of Health highly values the role of pharmaceutical companies in providing high-quality products, especially as Vietnam’s pharmaceutical industry faces numerous challenges and increasing regulatory demands from international authorities. The Ministry of Health is always ready to support businesses, including Cuu Long Pharmaceutical and Benovas, in improving product quality and optimizing production processes to meet international standards.”
Mr. Nguyen Thanh Lam Speaks at the Working Session
During the session, Ms. Nguyen Thi Thu Huong provided an overview of the history, development, and achievements of Cuu Long Pharmaceutical and Benovas over the years. Established with the mission of connecting and improving community well-being through optimal healthcare solutions, Cuu Long Pharmaceutical and Benovas have become reputable enterprises in Vietnam’s pharmaceutical and medical equipment sectors. Their contributions extend beyond manufacturing to the development of innovative products that meet market demands.
Ms. Nguyen Thi Thu Huong Shares an Overview of Cửu Long Pharmaceutical.
Following this, Mr. Nguyen Ba The – Business Development Director of Cuu Long Pharmaceutical – and Mr. Nguyen Toan Thang – General Director of Benovas Medical Equipment JSC – presented the current state, challenges, and proposed solutions for the pharmaceutical, capsule, and medical equipment sectors. They outlined key issues and suggested approaches to overcome these challenges.
In response to the challenges and proposals presented by Cuu Long Pharmaceutical and Benovas, representatives from the Ministry of Health shared their perspectives and reaffirmed their commitment to working alongside businesses to resolve existing issues. The Ministry assured continued support for enterprises not only in technical aspects but also in improving regulatory processes, addressing legal and compliance matters, and expanding market access.
The working session between the Ministry of Health and Cuu Long Pharmaceutical, Benovas concluded successfully, helping the companies identify suitable solutions to existing challenges. This event marks a significant step in fostering the development of Cuu Long Pharmaceutical, Benovas, and Vietnam’s pharmaceutical industry as a whole. It contributes to public health protection and enhances the quality of domestically produced pharmaceuticals and medical equipment.
